Sign In
test

Ron Rosenstraus

Eversept Partners, Lp

Assets Managed
$1.896B
Holdings
117
Last Quarter
2026 - Q1
Filed Date
7d ago
Growth Rate
-4.43%(2Q avg: 16.17%)
Sustained Growth
0 quarters

Portfolio positions

This chart displays the top 10 holdings in Eversept Partners, Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 117 positions.

Assets under management

The assets under management (AUM) of Eversept Partners, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 1.896B in assets, with a quarterly growth rate of -4.43% and a 2-quarter average growth rate of 16.17%. The portfolio is managed by Ron Rosenstraus, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
UTHR
United Therapeutics Corp
Recent Activity
Increased 4.63%
8.27%
$156.707M
264,271 shares@ $592.99 avg price
QQQ
Invesco Qqq Trust Series 1
Recent Activity
Increased 6.09%
7.27%
$137.773M↓ Put
238,700 shares@ $577.18 avg price
ABVX
Abivax Sa-adr
Recent Activity
Increased 42.05%
5.49%
$104.048M
934,423 shares@ $111.35 avg price
GSK
Gsk Plc-spon Adr
Recent Activity
Decreased -33.38%
5.2%
$98.524M
1.785M shares@ $55.19 avg price
VERA
Vera Therapeutics Inc
Recent Activity
Decreased -29.26%
4.62%
$87.431M
2.173M shares@ $40.24 avg price
NTRA
Natera Inc
Recent Activity
Increased 15.02%
4.06%
$76.939M
384,713 shares@ $200.0 avg price
SPY
Spdr S&p 500 Etf Trust
Recent Activity
Increased 138.31%
3.67%
$69.586M↓ Put
107,000 shares@ $650.34 avg price
SNDX
Syndax Pharmaceuticals Inc
Recent Activity
Decreased -12.93%
3.56%
$67.408M
2.886M shares@ $23.37 avg price
CLDX
Celldex Therapeutics Inc
Recent Activity
Increased 24.63%
3%
$56.716M
1.788M shares@ $31.73 avg price
PCVX
Vaxcyte Inc
Recent Activity
Decreased -22.83%
2.84%
$53.705M
924,193 shares@ $58.11 avg price

1-10 of 117